Polycationic Triblock Copolymer Micelles for Peptide Stability

The patent uses polyion complexes as an intermediary system to protect peptides from enzymatic degradation. Instead of directly modifying the peptide with PEG (which complicates the structure), the peptide is encapsulated within polyion complex micelles formed by the triblock copolymer and polyanionic polymer. This intermediary approach provides stability without requiring complex chemical modifications of the peptide itself.

The patent changes the physical state and composition parameters of the polymer system. Instead of using traditional polymer matrixes that cause inflammation, the invention uses self-assembled polyion complex micelles with specific charge ratios and molecular weights. The triblock copolymer contains cyclic nitroxide radicals that can scavenge reactive oxygen species, reducing inflammation. The system transitions from a static matrix to dynamic, biodegradable micelles that respond to biological environments.

The patent creates a composite material system combining a polycationic triblock copolymer with cyclic nitroxide radicals and a polyanionic polymer. This composite forms polyion complex micelles that can load peptides through electrostatic interactions. The cyclic nitroxide radicals provide antioxidant properties that enhance stability in biological environments, while the amphiphilic structure enables peptide loading. The composite nature allows simultaneous achievement of high loading capacity and environmental stability.

The patent employs a nested structure where the peptide is encapsulated within the polyion complex micelle core. The triblock copolymer and polyanionic polymer form the protective outer shell, creating a nested arrangement similar to dolls within dolls. This nested structure protects the peptide from enzymatic degradation in the bloodstream, improving bioavailability, while allowing controlled release at the target site to maintain therapeutic activity.